Riskpilot← Back to searchSign inGet full accessAux Iugis AB
ABActiveOrg 5592012578Böle 345 BölebergetHospital activities · NACE 8610Est. 20190 employees
Revenue 2024
SEK 339K
-67% vs 2023
EBITDA margin
95.4%
+149% vs 2023
Equity ratio
42.1%
Financial strength
Net profit 2024
SEK 254K
+180% vs 2023
| Revenue | SEK 339K | -67% |
| EBITDA | SEK 323K | +149% |
| Net profit | SEK 254K | +180% |
| Total assets | SEK 2,2M | -15% |
| Equity | SEK 936K | -5% |
| Employees | 0 | — |
Legal name
Aux Iugis AB
Org number
5592012578
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
3 april 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva uthyrning av läkarpersonal både till öppen- och slutenvård, vårdrelaterade utbildningar och föreläsningar samt medicinsk konsultverksamhet med fokus på organisationsutveckling och därmed förenlig verksamhet.
Address
Böle 345 Böleberget
Email
johannes.eimer@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 279 | 2 945 | 1 286 | 1 029 | 339 |
| Staff expenses | — | — | −747 | −805 | −0 |
| EBITDA | 130 | 2 117 | 418 | 130 | 323 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 130 | 2 117 | 418 | 130 | 323 |
| Net financials | — | — | −11 | −8 | 4 |
| Profit before tax | 130 | 1 592 | 301 | 121 | 327 |
| Tax | −28 | −328 | −66 | −30 | −73 |
| Net profit | 102 | 1 264 | 235 | 91 | 254 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 445 | 3 196 | 2 700 | 2 617 | 2 221 |
| Equity | 152 | 1 314 | 1 269 | 988 | 936 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 293 | 1 357 | 800 | 998 | 655 |
| Total debt | 293 | 1 357 | 800 | 998 | 655 |
EBITDA margin
95.4%
This company
15.8%
Market median
+504% vs market
20202024
Equity ratio
42.1%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
27.2%
This company
18.4%
Market median
+48% vs market
20202024
Net profit margin
75.0%
This company
8.1%
Market median
+826% vs market
20202024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20202024
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aux Iugis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johannes Michael Eimer | Chief Executive Officer | 0 companies |
| John Petter Karlsson Valik | Deputy Board Member | 0 companies |